UnknownNot Applicable

Telemonitoring in NIV MND (OptNIVent)

15 participantsStarted 2022-04-25

Plain-language summary

This is a feasibility study of telemonitoring system for people with MND/ALS, who are on NIV, via a call centre operated by a local clinical commissioning group.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria (Patients): * Confirmed diagnosis of MND with respiratory muscle weakness * Adults who are capable of informed consent * Patients for whom we anticipate survival of 6 months or more * Able to communicate with an interviewer. Alternative communication methods will be used as required in order to mitigate communication difficulties. Exclusion Criteria (Patients): * Patients who have declined NIV

What they're measuring

Acceptability - Qualitative data through semi-structured interviews and focus groups

Timeframe: Qualitative data will be conducted at 3-month

Usability - Qualitative data through semi-structured interviews and focus groups

Timeframe: Qualitative data will be conducted at 3-month

Trial details

NCT IDNCT05299372

SponsorLiverpool University Hospitals NHS Foundation Trust

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-10-31

Contact for this trial

Hikari Ando, PhD

0151529 hikari.ando@nhs.net

View on ClinicalTrials.gov More Motor Neuron Disease, Amyotrophic Lateral Sclerosis trials